Search

Search Results
Results 17661 - 17670 of 17706 for Depression
  • Buscopan 10mg tablets
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan 10mg tablets intended for persons living in Australia.
  • Buscopan Injection
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Injection intended for persons living in Australia.
  • Buscopan Forte
    Drug - 28 Dec 2020
    Consumer Medicine Information (CMI) about Buscopan Forte intended for persons living in Australia.
  • Onbrez Breezhaler
    Drug - 16 Dec 2020
    Consumer Medicine Information (CMI) about Onbrez Breezhaler (Indacaterol maleate) intended for persons living in Australia.
  • Ultibro Breezhaler 110/50
    Drug - 15 Dec 2020
    Consumer Medicine Information (CMI) about Ultibro Breezhaler 110/50 (Indacaterol maleate/ Glycopyrronium bromide) intended for persons living in Australia.
  • Sevorane
    Drug - 20 Nov 2020
    Consumer Medicine Information (CMI) about Sevorane intended for persons living in Australia.
  • Cyprone 50
    Drug - 7 Sep 2020
    Consumer Medicine Information (CMI) about Cyprone 50 (contains cyproterone acetate) intended for persons living in Australia.
  • Cyprone 100
    Drug - 7 Sep 2020
    Consumer Medicine Information (CMI) about Cyprone 100 (contains cyproterone acetate) intended for persons living in Australia.
  • Synacthen Depot
    Drug - 6 Aug 2020
    Consumer Medicine Information (CMI) about Synacthen Depot (tetracosactide) intended for persons living in Australia.
  • Riamet
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet (Artemether and lumefantrine) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback